The private label cosmetics manufacturing process typically takes between 8 and 20 weeks from initial brief to finished product, depending on the complexity of your formulation, your packaging choices, and how quickly decisions are made along the way. For brands working with ready-made base formulations, timelines can sit closer to 8 to 12 weeks. Custom development projects tend to run 16 to 20 weeks or longer. Below, we break down exactly what drives that timeline and how you can keep things moving.
The private label cosmetics manufacturing process is made up of five core stages: briefing and formulation selection, sample development and approval, regulatory and compliance review, packaging procurement, and full-scale production and filling. Each stage builds on the previous one, and skipping or rushing any step tends to create problems downstream.
Here is a closer look at what each stage involves:
Each stage of the cosmetics manufacturing process carries its own timeline. As a general guide: briefing takes 1 to 2 weeks, sample development runs 2 to 6 weeks, regulatory review adds 2 to 4 weeks, packaging procurement can take 4 to 8 weeks, and production itself typically takes 2 to 4 weeks. These stages often overlap, but delays in any one can push back the entire schedule.
Packaging procurement is frequently the longest and most unpredictable stage, especially for brands sourcing custom or low-minimum packaging components. Standard stock packaging components move faster, while custom-printed or uniquely shaped containers require longer lead times and sometimes minimum order quantities that affect your budget as well as your timeline.
Sample approval is the other variable stage. If your first sample hits the mark, you move quickly. If adjustments are needed, whether to fragrance, consistency, or colour, each revision cycle adds one to two weeks. Being clear and specific in your feedback speeds this up considerably.
The most common factors that slow down a cosmetics manufacturing timeline are delayed decision-making on the brand side, raw material sourcing challenges, packaging lead times, and the number of sample revision rounds required. Regulatory complexity and third-party certification requirements can also add weeks to a project.
Some specific situations that frequently cause delays include:
External factors like global supply chain disruptions can also affect raw material availability and shipping times, which is worth factoring into your planning, especially when working with a 100% natural ingredient portfolio.
You can speed up the private label manufacturing process by starting with a clear and detailed brief, choosing stock packaging over custom components, limiting sample revision rounds through precise feedback, and beginning regulatory preparation in parallel with formulation development rather than after it.
A few practical steps that make a real difference:
The key difference is that private label products use existing, pre-developed formulations that are adapted with your branding, while custom formulations are developed from scratch to your specific requirements. Private label timelines typically run 8 to 12 weeks; custom formulation projects run 16 to 24 weeks or more, because the formulation development phase is substantially longer and involves more testing iterations.
For startups and emerging brands launching their first products, private label is often the faster and more cost-effective route to market. You benefit from a formulation that has already been tested and validated, which reduces both development risk and time. Custom formulation makes more sense when your brand’s point of difference depends on a genuinely unique product that cannot be achieved through an existing base.
Rebel Nature is a natural cosmetics manufacturer built to guide brands through every stage of the private label process — from first brief to finished product — with full transparency on timelines, formulation options, and regulatory requirements. Whether you are launching your first SKU or scaling an existing range, here is what working with Rebel Nature looks like in practice:
If you are ready to start your private label project or want to understand what a realistic timeline looks like for your specific brief, get in touch with the Rebel Nature team and we will walk you through the options.
A strong brief should cover your target consumer profile, desired product texture and finish, scent direction or specific fragrance preferences, any ingredients you want included or excluded, required certifications (such as organic, vegan, or cruelty-free), your intended market (e.g. EU, UK, US), and your target launch date. The more detail you provide upfront, the less back-and-forth is needed during formulation selection, which can save you one to three weeks in the early stages alone.
Minimum order quantities (MOQs) vary between manufacturers and depend on the product type, formulation complexity, and packaging choice. Many private label manufacturers offer low MOQs for stock formulations and standard packaging — sometimes as low as 100 to 500 units — making it accessible for emerging brands testing the market. Custom formulations and bespoke packaging components generally carry higher MOQs, so it is worth clarifying this early in your conversations to ensure the numbers align with your budget and sales projections.
EU compliance requires a completed Product Information File (PIF), which includes a cosmetic product safety report (CPSR) signed off by a qualified safety assessor, an ingredient list compliant with INCI naming conventions, and a stability and challenge test where applicable. A reputable private label manufacturer will either handle this process on your behalf or work alongside your appointed Responsible Person. It is important to confirm who holds the Responsible Person role for your product before it is placed on the EU or UK market, as this carries legal accountability.
Yes, but changes made after an initial production run — such as adjusting a fragrance, swapping an ingredient, or updating the formula — will typically restart parts of the development and regulatory process, including a new safety assessment if the formulation changes materially. Minor label or packaging updates are generally simpler to implement. If you anticipate wanting to iterate on your product, it is worth discussing a phased development approach with your manufacturer from the outset so changes can be planned efficiently rather than reactively.
The most frequent mistakes include underestimating packaging lead times and leaving procurement too late, providing vague or evolving briefs that cause formulation work to restart, and treating regulatory compliance as an afterthought rather than a parallel workstream. Many first-time brands also underestimate how many sample revision rounds they will need, which adds weeks to the timeline. Working with a manufacturer who guides you through each stage — rather than simply executing instructions — can help you avoid these pitfalls, especially on your first product launch.
Launching multiple SKUs at the same time is possible, but it multiplies the complexity across every stage — more samples to review, more packaging components to procure, and more regulatory files to complete in parallel. Many brands find it more manageable to launch a hero product first and expand the range once that initial process is understood. If you do want to launch several products together, ensure you have the internal resource to review samples and provide feedback promptly across all SKUs, as slow approvals on one product can create a bottleneck for the entire range.
As a rule of thumb, work backwards from your target launch date and add a minimum of 12 weeks for a private label product with stock packaging, or 20 to 24 weeks if you are pursuing a custom formulation or bespoke packaging. It is also wise to build in a two to four week buffer for unforeseen delays such as shipping disruptions or additional sample revision rounds. If your launch is tied to a seasonal campaign, a trade show, or a retail window, sharing that deadline with your manufacturer at the briefing stage allows them to flag any risks to the schedule early.